Translation
Feb 03, 2010
| Name of listed company: |  |
Chugai Pharmaceutical Co., Ltd. |
| Code number: | 4519 (1st Section of Tokyo Stock Exchange) | |
| Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo | |
| President & CEO: | Osamu Nagayama | |
| Inquiries to: | Nobuyuki Chiba, General Manager, Corporate Communications Dept. |
|
| Tel:+81-(0)3-3273-0881 |
F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today, its financial results for fiscal 2009 (January 1 – December 31, 2009).
Roche owns 59.9% of Chugai's outstanding shares (61.6% of voting rights) as of end of December 2009.
Its press release and presentation materials can be found on its Website (http://www.roche.com).
| Media Release | Presentation | Annual Report 2009 |
Chugai’s sales for the period of January 1 to December 31, 2009 are included in the announced Roche Group’s sales. These results are based on Roche’s accounting policies which conform to International Financial Reporting Standards, which differ from generally accepted accounting standards in Japan.
[
PDF 67KB]
To view PDF files,
you will need Adobe® Reader® which is available as a free download.
